Friday, August 28, 2015 4:08:09 PM
RP seemed rather straight forward. A number of companies have submitted for RP orphan over the years. I haven't see the same activity for RAO. Actually none, but haven't spent a very long time looking. Two orphans on MANF would be incredible. One is great. Two is even better. I already posted the deal AGTC got with two orphans in ophthalmology with one reaching clinical (pipeline -> http://www.agtc.com/products)
Here's the July meeting:
Committee for Orphan Medicinal Products (COMP)
Draft agenda for the meeting on 14-16 July 2015
2.2.13. - EMA/OD/079/15
Treatment of retinal artery occlusion
Action: For adoption
Documents tabled:
Draft Summary report
http://www.ema.europa.eu/docs/en_GB/document_...189364.pdf
Here's the link to watch:
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/document_listing/document_listing_000201.jsp&mid=WC0b01ac0580028e78
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM